Form 4 for CRSP CRISPR Therapeutics AG
Accepted 2026-01-27 00:00:00 ET · period of report 2025-04-03 · accession 0001193125-26-024955 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-27 | 2025-04-03 | CRSP | Patel Naimish | Chief Medical Off | P - Purchase | $32.96 | +1,508 | 1,508 | New | +$49.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-04-03 | P | A | 1,508 | $32.96 | 1,508 | D | — | — |